Opus Genetics IRD
NASDAQ IRD
$4.11 +0.10 (+2.62%)
At close: Oct 21, 2026 · 4:00 PM EDT

Opus Genetics (IRD) Notes Payables (2019 - 2022)

Updated

Opus Genetics' Notes Payables came in at $215,000 for Q1 2022, down 60.0% from the prior quarter.

Analysis

Opus Genetics (IRD) Notes Payables (2019 - 2022) Analysis & Trends

At the end of FY2021, Opus Genetics' Notes Payables was $538,000.

  • Going back by year, Notes Payables was $4.98 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Opus Genetics 391.96 Mn 167.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 215,000.00
Dec 31, 2021 538,000.00
Dec 31, 2019 4.98 Mn
API Access

Opus Genetics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=IRD&period=max&api_key=YOUR_API_KEY